Thomas Foltynie - Concepedia

Author

Thomas Foltynie

Also Known As

Butterworth, Adam S., Foltynie T, Foltynie, T, Foltynie, T., MRC CFAS, Roger A. Barker, Steven Finkbeiner, T Foltynie, T. Foltynie, T. Tom Foltynie

549

Publications

36.6K

Citations

H-Index

131

Concepts

All Affiliations

University College London National Hospital for Neurology and Neurosurgery University of Oxford Sobell House King's College London

About

Thomas Foltynie is an author at University College London specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	37	5K
2	Health Sciences	10	10	1.2K
3	Engineering	2	2	99
4	Arts	1	1	22
5	Natural Sciences	1	1	180

Thomas Foltynie

169

Publications

20.1K

Citations

H-Index

Page 1

	Year	Citations
Adaptive deep brain stimulation in advanced Parkinson disease Simon Little, A Pogosyan, Spencer Neal, Annals of Neurology	2013	1.3K
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort Caroline H. Williams‐Gray, Jonathan Evans, An Goris, Brain	2009	946
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial Dilan Athauda, Kate Maclagan, Simon S. Skene, The Lancet Psychotropic MedicationClinical TrialsPsychopharmacologyNeuropharmacologyWeekly Versus Placebo	2017	811
Mild cognitive impairment in Parkinson disease Dag Aarsland, Caroline H. Williams‐Gray, Daniel Weintraub, Neurology	2010	728
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study Thomas Foltynie, Carol Brayne, Trevor W. Robbins, Brain Corticobasal DegenerationDiagnosisIncident CohortCognitive RehabilitationNeurology	2004	686
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort Caroline H. Williams‐Gray, Sarah Mason, Jonathan Evans, Journal of Neurology Neurosurgery & Psychiatry	2013	671
Exenatide and the treatment of patients with Parkinson’s disease Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou, Journal of Clinical Investigation	2013	494
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease Laurie Robak, Iris E. Jansen, Jeroen van Rooij, Brain GeneticsGenetic EpidemiologyVariant BurdenDisease Gene IdentificationGenome-wide Association Study	2017	440
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy Suzanne Lesage, Valérie Drouet, Elisa Majounie, The American Journal of Human Genetics Cell AutophagyMitophagyMitochondrial FunctionGeneticsAutophagy	2016	427
Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients Alexandre Eusébio, Wesley Thevathasan, Louise Doyle Gaynor, Journal of Neurology Neurosurgery & Psychiatry	2010	413

Page 1